Skip to content

H.R. 2707 · 118th Congress (2023–2025)

MADE in America Act

This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products.

Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone.

The bill defines distressed zone as an area that has been designated as a qualified opportunity zone by the Internal Revenue Service (i.e., an economically distressed community in which certain new investments may be eligible for preferential tax treatment) and that has a poverty rate of over 30%.

Show official title

To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to Health

This bill’s path

This is H.R. 2707’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Earl L. "Buddy" Carter (R-GA-1)
Cosponsors
13 cosponsors

11 original · 2 later

11 R · 2 D

  1. Rep. Gus M. Bilirakis (R-FL-12)· Original · Apr 19, 2023
  2. Rep. Troy Balderson (R-OH-12)· Original · Apr 19, 2023
  3. Rep. Eric A. "Rick" Crawford (R-AR-1)· Original · Apr 19, 2023
  4. Rep. Matt Cartwright (D-PA-8)· Original · Apr 19, 2023
  5. Rep. H. Morgan Griffith (R-VA-9)· Original · Apr 19, 2023
  6. Rep. Richard Hudson (R-NC-9)· Original · Apr 19, 2023
  7. Rep. Diana Harshbarger (R-TN-1)· Original · Apr 19, 2023
  8. Rep. Nicholas A. Langworthy (R-NY-23)· Original · Apr 19, 2023
  9. Rep. Carol D. Miller (R-WV-1)· Original · Apr 19, 2023
  10. Rep. Darren Soto (D-FL-9)· Original · Apr 19, 2023
  11. Rep. Jefferson Van Drew (R-NJ-2)· Original · Apr 19, 2023
  12. Rep. Ronny Jackson (R-TX-13)· Later · May 23, 2023
  13. Rep. John H. Rutherford (R-FL-5)· Later · Jan 17, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 2 committee actions · Apr 19, 2023 – Dec 17, 2024
    1. Referred to committee

      Referred to the House Committee on Ways and Means.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
  3. Expired

    Introduced → Referred to House Health → No further action before the 118th Congress ended.

Committees

  1. HouseWays and MeansReferred Apr 19, 2023
  2. HouseHealthReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (3)
  1. MADE in America Act

    Display title, Short title · Introduced in House

  2. Manufacturing API, Drugs, and Excipients in America Act

    Short title · Introduced in House

  3. To mitigate drug shortages and provide incentives for maintaining, expanding, and relocating the manufacturing of active pharmaceutical ingredients, excipients, medical diagnostic devices, pharmaceuticals, and personal protective equipment in the United States, and for other purposes.

    Official title · Introduced in House